MedKoo Cat#: 525006 | Name: Emylcamate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Emylcamate is an anxiolytic and muscle relaxant. It was patented in the US in 1961 (US Patent 2,972,564) and advertised for the treatment of anxiety and tension.

Chemical Structure

Emylcamate
Emylcamate
CAS#78-28-4

Theoretical Analysis

MedKoo Cat#: 525006

Name: Emylcamate

CAS#: 78-28-4

Chemical Formula: C7H15NO2

Exact Mass: 145.1103

Molecular Weight: 145.20

Elemental Analysis: C, 57.90; H, 10.41; N, 9.65; O, 22.04

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Emylcamate; Emilcamato; Emylcamat; Nuncital; Psicoplegil; Restetal; Stratran; Striatan; Striatran; Statran; KABI-925; Kabi-295; tert-Hexyl carbamate; MK-250.
IUPAC/Chemical Name
1-Ethyl-1-methylpropyl carbamate
InChi Key
SLWGJZPKHAXZQL-UHFFFAOYSA-N
InChi Code
InChI=1S/C7H15NO2/c1-4-7(3,5-2)10-6(8)9/h4-5H2,1-3H3,(H2,8,9)
SMILES Code
C(OC(=O)N)(CC)(CC)C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 145.20 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Charnoff SM. Long-term treatment of alcoholism with amitriptyline and emylcamate. A double-blind evaluation. Q J Stud Alcohol. 1967 Jun;28(2):289-94. PubMed PMID: 4860508. 2: DARBELLAY J. [THE ORTHONEUROTIC EMYLCAMATE IN DAILY PRACTICE]. Brux Med. 1963 Oct 6;43:1009-19. French. PubMed PMID: 14052966. 3: SHUBIN H, STEINBERG N. A STUDY OF A NEW TRANQUILIZER IN GENERAL PRACTICE: EMYLCAMATE IN 400 PATIENTS. Curr Ther Res Clin Exp. 1963 Oct;5:527-33. PubMed PMID: 14074232. 4: BERTELSON P, JOFFE R. [Effect of meprobamate and emylcamate on human performance in a prolonged serial task]. Psychopharmacologia. 1962 Oct 5;3:242-53. French. PubMed PMID: 13966735. 5: CARTER CH. Emylcamate in hospitalized mentally retarded spastic patients. Dis Nerv Syst. 1962 Apr;23:211-6. PubMed PMID: 13876949. 6: MANDARINO MP. Emylcamate--its use in orthopedic practice. Arch Surg. 1961 Aug;83:296-9. PubMed PMID: 13766048. 7: YOUNG R. Striatran (1-ethyl-1-methyl propyl carbamate), a new internucial blocking ataraxic: a study of 203 cases. Int Rec Med. 1961 Jun;174:345-8. PubMed PMID: 13787481. 8: JONSSON CO, ANDERSEN K. Influence of emylcamate, meprobamate, and placebo on psychologic test performance. Clin Pharmacol Ther. 1960 Nov-Dec;1:708-15. PubMed PMID: 13790642. 9: UHR L, MILLER JG. Behavioral toxicity of emylcamate (striatran). Am J Med Sci. 1960 Aug;240:197-203. PubMed PMID: 14405494. 10: UHR L, MILLER JG. Experimentally determined effects of emylcamate (striatran) on performance, autonomic response, and subjective reactions under stress. Am J Med Sci. 1960 Aug;240:204-12. PubMed PMID: 13779033. 11: MARTENS S. Clinical trial of emylcamate, a new internuncial blocking tranquilizer. A double-blind study in alcoholic out-patients. Q J Stud Alcohol. 1960 Jun;21:223-32. PubMed PMID: 14421603.